Publication:
Lifesaving Dose Increment of Cabergoline in Life-Threatening Spontaneous Ovarian Hyperstimulation Syndrome Resistant to All Interventions

dc.contributor.authorCelik, Samettin
dc.contributor.authorSoyer-Caliskan, Canan
dc.contributor.authorHatirnaz, Safak
dc.contributor.authorCelik, Handan
dc.contributor.authorTosun, Migraci
dc.contributor.authorHatirnaz, Ebru S.
dc.contributor.authorIDHatirnaz, Safak/0000-0001-8859-0639
dc.date.accessioned2020-06-21T12:27:11Z
dc.date.available2020-06-21T12:27:11Z
dc.date.issued2019
dc.departmentOMÜen_US
dc.department-temp[Celik, Samettin -- Soyer-Caliskan, Canan] Matern Hosp, Samsun, Turkey -- [Hatirnaz, Safak -- Hatirnaz, Ebru S.] Medicana Int Hosp, IVF Ctr, Samsun, Turkey -- [Celik, Handan -- Tosun, Migraci] Ondokuz Mayis Univ, Dept Obstet & Gynecol, Samsun, Turkey --en_US
dc.description.abstractObjective: Spontaneous ovarian hyperstimulation syndrome (SOHSS) is an extremely rare complication that deserves a multidisciplinary approach together with a thorough investigation for the correct diagnosis of the underlying pathology. The aim of this study was to present a case of severe SOHSS resistant to all interventions and to discuss the available interventions to overcome such a rare and serious clinical situation. Case report: We report a case of severe, life-threatening spontaneous OHSS with a normal nine weeks singleton pregnancy in a 25-year-old nulliparous woman, which resulted with pregnancy termination and continuation of disease progression until the dose of cabergoline was increased to 1.5 mg/day. Conclusion: This case report emphasizes that patients with life-threatening SOHSS resistant to all medical and surgical interventions may benefit from higher doses of cabergoline. Although spontaneous OHSS is extremely rare, it is potentially a life-threatening clinical entity in its severe form and needs time management and detailed examination of the underlying causes.en_US
dc.identifier.doi10.1080/09513590.2018.1525703
dc.identifier.endpage289en_US
dc.identifier.issn0951-3590
dc.identifier.issn1473-0766
dc.identifier.issue4en_US
dc.identifier.pmid30560702
dc.identifier.startpage287en_US
dc.identifier.urihttps://doi.org/10.1080/09513590.2018.1525703
dc.identifier.urihttps://hdl.handle.net/20.500.12712/10886
dc.identifier.volume35en_US
dc.identifier.wosWOS:000465210500003
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.journalGynecological Endocrinologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSpontaneous Ovarian Hyperstimulation Syndromeen_US
dc.subjectSingleton Pregnancyen_US
dc.subjectPregnancy Terminationen_US
dc.subjectCabergolineen_US
dc.titleLifesaving Dose Increment of Cabergoline in Life-Threatening Spontaneous Ovarian Hyperstimulation Syndrome Resistant to All Interventionsen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files